China's 14th Five-Year Plan for Biological Economy Development Arrangements places emphasis on accelerating and refining vaccine R&D and production technology. This document encourages the development of multi-disease and polyvalent vaccines and novel genetically engineered vaccines.
The platform utilizes its cutting-edge gene editing technology and virus strains with exclusive intellectual property rights to develop genetically engineered viral vector vaccines. The goal is to develop multi-disease and polyvalent new marker vaccines capable of preventing multiple diseases. By doing so, the company can contribute to streamlining immunization programs and managing and controlling diseases.